Clinical Trial Matcher

NCT07322757

Outcomes-Based Health Program for Type 2 Diabetes

Recruiting · Not Applicable · Kuopio University Hospital · registry updated 2026-01-07

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

Type 2 diabetes is a growing health concern worldwide, influenced by genetic factors, overweight, metabolic syndrome, and insufficient physical activity. Good treatment and glycemic control can reduce or delay diabetes-related complications, which account for a significant and increasing share of healthcare costs in Finland. Much of this cost growth is due to complications resulting from inadequate diabetes care. Secondary prevention programs can therefore provide both health and economic benefits. Lifestyle interventions are one way to improve type 2 diabetes care and reduce complications. This study aims to evaluate the impact of a digital lifestyle intervention combined with optimized care on treatment and outcomes among adults with type 2 diabetes at high risk for complications. The intervention includes access to the BitHabit "Small Actions" application, which supports healthy lifestyle changes, and for participants with a body mass index (BMI) over 30, the Onnikka weight management application. The study will be conducted in North Savo, Finland, using a case-control design. Approximately 120 participants will receive the intervention and 50-100 will serve as controls....

Inclusion

  • Type 2 diabetes diagnosed
  • At least one of the following:
  • diagnosed coronary artery disease,
  • diagnosed periferal artery disease,
  • diagnosed heart failure,
  • diagnosed diabetic renal disease (GFR \<60 OR uACR ≥ 3 for at least three months),

Exclusion

  • heart ejection fraction EF \< 30
  • active cancer or less than five years from cancer treatment at enrollment
  • blindness in both eyes
  • severe psychotic depression
  • inability to utilize digital applications

Open NCT07322757 on ClinicalTrials.govAll conditions